• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢危险因素患者的原位心脏移植。

Orthotopic heart transplantation in patients with metabolic risk factors.

机构信息

Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins Medical Institutions Baltimore, Maryland, USA.

出版信息

Ann Thorac Surg. 2012 Mar;93(3):718-24. doi: 10.1016/j.athoracsur.2011.11.054. Epub 2012 Feb 2.

DOI:10.1016/j.athoracsur.2011.11.054
PMID:22305053
Abstract

BACKGROUND

The aim of this study was to evaluate the impact of metabolic risk factors on mortality rates after orthotopic heart transplantation (OHT).

METHODS

Adult patients undergoing OHT between 1998 and 2008 were identified in the United Network for Organ Sharing registry. The impact of metabolic risk factors (hypertension, diabetes mellitus, and obesity) on mortality post-OHT was evaluated in a Cox proportional hazards regression analysis adjusted for other variables associated with survival in univariate analysis (exploratory p value<0.2). Kaplan-Meier survival estimates were compared with the log-rank test.

RESULTS

A total of 15,960 eligible patients underwent OHT during the study period. There were 6,368 (39.9%) patients with none of these risk factors, 6,138 (38.5%) with 1 risk factor, 2,811 (17.6%) with 2 risk factors, and 643 (4.0%) who had all 3 risk factors. After adjusting for other significant variables influencing survival, each individual risk factor independently increased the likelihood of mortality post-OHT (hypertension: HR 1.10 [1.03 to 1.17]; diabetes: HR 1.22[1.13 to 1.31]; obesity: HR 1.17 [1.10 to 1.26], each p<0.01). There was an exponential trend of increasing mortality with the addition of each risk factor (r2=0.99, p<0.001) such that patients with all 3 risk factors had a 63% increased mortality compared with those with no risk factors (HR 1.63 [1.42 to 1.88], p<0.001). There was also a significant trend in declining 5-year survival rates with an increasing number of risk factors: 0 (74.7%), 1 (71.3%), 2 (68.2%), and 3 (63.1%) (p<0.001).

CONCLUSIONS

This large-cohort study demonstrates that an increasing number of metabolic risk factors in OHT recipients is associated with exponential increases in postoperative mortality rates.

摘要

背景

本研究旨在评估代谢危险因素对原位心脏移植(OHT)后死亡率的影响。

方法

在美国器官共享网络注册中心确定了 1998 年至 2008 年间接受 OHT 的成年患者。使用 Cox 比例风险回归分析评估代谢危险因素(高血压、糖尿病和肥胖)对 OHT 后死亡率的影响,该分析调整了单变量分析中与生存相关的其他变量(探索性 p 值<0.2)。使用对数秩检验比较 Kaplan-Meier 生存估计值。

结果

在研究期间,共有 15960 名符合条件的患者接受了 OHT。其中 6368 名(39.9%)患者无上述风险因素,6138 名(38.5%)患者有 1 个风险因素,2811 名(17.6%)患者有 2 个风险因素,643 名(4.0%)患者有 3 个风险因素。在调整其他影响生存的重要变量后,每个单独的风险因素都独立增加了 OHT 后死亡的可能性(高血压:HR 1.10[1.03 至 1.17];糖尿病:HR 1.22[1.13 至 1.31];肥胖:HR 1.17[1.10 至 1.26],均<0.01)。随着每个风险因素的增加,死亡率呈指数增长趋势(r2=0.99,<0.001),因此,与无风险因素的患者相比,具有 3 个风险因素的患者死亡率增加了 63%(HR 1.63[1.42 至 1.88],<0.001)。随着危险因素数量的增加,5 年生存率呈显著下降趋势:0(74.7%)、1(71.3%)、2(68.2%)和 3(63.1%)(<0.001)。

结论

这项大型队列研究表明,OHT 受者的代谢危险因素数量增加与术后死亡率呈指数增长相关。

相似文献

1
Orthotopic heart transplantation in patients with metabolic risk factors.代谢危险因素患者的原位心脏移植。
Ann Thorac Surg. 2012 Mar;93(3):718-24. doi: 10.1016/j.athoracsur.2011.11.054. Epub 2012 Feb 2.
2
Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.60岁以上患者原位心脏移植的结果:对器官共享联合网络(UNOS)数据库的分析
J Heart Lung Transplant. 2008 Feb;27(2):184-91. doi: 10.1016/j.healun.2007.11.566.
3
Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation.受体体重指数对原位心脏移植中器官分配和死亡率的影响。
J Heart Lung Transplant. 2009 Nov;28(11):1150-7. doi: 10.1016/j.healun.2009.06.009. Epub 2009 Sep 26.
4
Institutional factors beyond procedural volume significantly impact center variability in outcomes after orthotopic heart transplantation.除了手术量以外,制度因素极大地影响了同种异体心脏移植术后中心间结果的变异性。
Ann Surg. 2012 Oct;256(4):616-23. doi: 10.1097/SLA.0b013e31826b4bc9.
5
Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation.威斯康星大学保存液器官保存与原位心脏移植后改善结局相关。
J Heart Lung Transplant. 2011 Sep;30(9):1033-43. doi: 10.1016/j.healun.2011.05.005. Epub 2011 Jun 17.
6
Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT).创建心脏移植后死亡率预测的定量受体风险指数 (IMPACT)。
Ann Thorac Surg. 2011 Sep;92(3):914-21; discussion 921-2. doi: 10.1016/j.athoracsur.2011.04.030.
7
Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation.建立一个定量的供者风险指数以预测原位心脏移植术后短期死亡率。
J Heart Lung Transplant. 2012 Mar;31(3):266-73. doi: 10.1016/j.healun.2011.10.004. Epub 2011 Nov 16.
8
Marital status improves survival after orthotopic heart transplantation.婚姻状况改善了原位心脏移植后的存活率。
J Heart Lung Transplant. 2011 Dec;30(12):1389-94. doi: 10.1016/j.healun.2011.07.020. Epub 2011 Sep 9.
9
Adult-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) risk score predicts short-term mortality after pediatric heart transplantation.成人心脏移植后死亡率预测指数(IMPACT)风险评分可预测小儿心脏移植后的短期死亡率。
Ann Thorac Surg. 2012 Apr;93(4):1228-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2011.12.055. Epub 2012 Mar 2.
10
Insurance and education predict long-term survival after orthotopic heart transplantation in the United States.保险和教育可预测美国原位心脏移植术后的长期存活率。
J Heart Lung Transplant. 2012 Jan;31(1):52-60. doi: 10.1016/j.healun.2011.07.019. Epub 2011 Oct 1.

引用本文的文献

1
Synergistic Integration of Multimodal Metabolic and Bariatric Interventions Transforming Transplant Care.多模式代谢与减重干预的协同整合变革移植护理
J Clin Med. 2025 Aug 11;14(16):5669. doi: 10.3390/jcm14165669.
2
Intra-operative Risk Factors Affecting Mortality after Heart Transplantation: A Referral Center Experience in Iran.心脏移植术后死亡率的术中相关危险因素:伊朗转诊中心的经验。
Iran J Med Sci. 2024 Jun 1;49(6):359-368. doi: 10.30476/ijms.2023.99165.3122. eCollection 2024 Jun.
3
Derivation and validation of the bridge to transplantation with left ventricular assist device score for 1 year mortality after heart transplantation. The BTT-LVAD score.
心脏移植后 1 年死亡率的桥接至移植左心室辅助装置评分的推导和验证。BTT-LVAD 评分。
Int J Artif Organs. 2022 May;45(5):470-477. doi: 10.1177/03913988221082690. Epub 2022 Apr 1.
4
Taurodeoxycholic acid and valine reverse obesity-associated augmented alloimmune responses and prolong allograft survival.牛磺脱氧胆酸和缬氨酸可逆转肥胖相关的增强性同种免疫反应,延长移植物存活时间。
Am J Transplant. 2022 Feb;22(2):402-413. doi: 10.1111/ajt.16856. Epub 2021 Oct 17.
5
Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.晚期心力衰竭患者心脏移植与单纯耐用机械循环支持候补策略。
JAMA Cardiol. 2020 Jun 1;5(6):652-659. doi: 10.1001/jamacardio.2020.0631.
6
Does Race Influence Decision Making for Advanced Heart Failure Therapies?种族会影响晚期心力衰竭治疗决策吗?
J Am Heart Assoc. 2019 Nov 19;8(22):e013592. doi: 10.1161/JAHA.119.013592. Epub 2019 Nov 11.
7
Clinical outcomes in overweight heart transplant recipients.超重心脏移植受者的临床结局
Heart Lung. 2016 Jul-Aug;45(4):298-304. doi: 10.1016/j.hrtlng.2016.03.005. Epub 2016 Apr 14.
8
The varying effects of obesity and morbid obesity on outcomes following cardiac transplantation.肥胖和病态肥胖对心脏移植术后结局的不同影响。
Int J Obes (Lond). 2016 Apr;40(4):721-4. doi: 10.1038/ijo.2016.20. Epub 2016 Feb 8.
9
Detection of circulating tumor cells in peripheral blood of colorectal cancer patients without distant organ metastases.检测无远处器官转移的结直肠癌患者外周血中的循环肿瘤细胞。
Cell Oncol (Dordr). 2013 Feb;36(1):43-53. doi: 10.1007/s13402-012-0112-6. Epub 2012 Nov 14.